Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
benefits of using cd38 inhibitor with 5-amino-1mq

benefits of using cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine Selective and membrane-permeable small molecule

Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC Full article: Anti CD38 monoclonal antibodies for multiple myeloma treatment The role of NAD+ metabolism and its modulation of mitochondria in aging and disease PMC US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents

SKU: 95984826083 · From www.marsberger-treibhaus.de

4.3
USD24.53 USD44.53

Pay in 4 interest-free payments of $6.13 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

10.1038/srep26933 143 TripathiB

benefits of using cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine Selective and membrane-permeable small molecule

Mechanism of Action Inhibits Nicotinamide N-Methyltransferase (NNMT) Increases intracellular nicotinamide and NAD levels Improves mitochondrial efficiency and energy metabolism Supports lipolysis and fat oxidation Reduces adipocyte (fat cell) growth and proliferation Modulates inflammatory pathways and insulin signaling These effects may lead to enhanced fat metabolism, better blood sugar regulation, improved endurance, and a general increase in metabolic flexibility

benefits of using cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine Selective and membrane-permeable small molecule

People with stomach and intestinal conditions such as celiac disease and Crohns disease may struggle to absorb enough B12 from their food

benefits of using cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine Selective and membrane-permeable small molecule

While clinical interactions have not been documented, combining multiple compounds that affect similar pathways increases unpredictability

benefits of using cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine Selective and membrane-permeable small molecule
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Frontiers

US$ 21.38

4.3 (6 reviews)

recommand products